Neos Therapeutics, Inc. (NASDAQ:NEOS)

About the company

Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

213

CEO

Gerald W. McLaughlin

Exchange

NASDAQ

Website

http://www.neostx.com

$65.00M

Total Revenue

213

Employees

$34.50M

Market Capitalization

-1.97

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$40M

Operating Margin (in %)

Total operating margin

$-11M

Net Margin (in %)

Total net margin

$-17M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12180.00 1376.00 5.19 19.21 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7433.62 4837.00 1.27 50.71 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6047.70 2188.00 2.09 22.10 12.81
United Therapeutics Corp. UTHR 5027.56 1443.00 1.75 9.70 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2415.84 435.00 6.48 -5752.00 -0.02
SAGE Therapeutics, Inc. SAGE 2295.80 9.00 2.70 -3.55 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2043.50 335.00 4.69 19.25 31.64
Prestige Consumer Healthcare, Inc. PBH 1816.11 963.00 1.53 12.81 14.77
Revolution Medicines, Inc. RVMD 1631.94 48.00 4.24 -23.05 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1615.50 0.00 4.31 -15.81 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1534.54 285.00 3.63 7.94 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1251.45 5.00 3.42 -2.94 -241.62
Theravance Biopharma, Inc. TBPH 1220.94 88.00 -8.57 -4.95 -280.80
Revance Therapeutics, Inc. RVNC 1190.98 0.00 4.70 -6.38 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1020.18 327.00 2.55 20.02 15.90
Endo International Plc ENDP 766.08 3014.00 -1.05 -2.73 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Assembly Biosciences, Inc. ASMB 680.34 16.00 3.05 -6.84 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 536.07 119.00 5.22 12.22 36.09
Anika Therapeutics, Inc. ANIK 486.78 125.00 1.68 17.56 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 329.29 11.00 3.35 -4.31 -730.55
MEI Pharma, Inc. MEIP 285.52 5.00 4.91 -7.32 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Marinus Pharmaceuticals, Inc. MRNS 151.20 0.00 5.85 -2.24 None
Agile Therapeutics, Inc. AGRX 147.85 None 2.41 -7.16 None
Cerecor, Inc. CERC 117.76 7.00 7.53 -5.22 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.38 1.00 68.80 -5.29 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 79.12 0.00 1.30 -2.21 -699.94
Aclaris Therapeutics, Inc. ACRS 73.80 4.00 1.29 -0.54 None
Adamas Pharmaceuticals, Inc. ADMS 70.84 57.00 -4.52 -0.76 -160.44
Oramed Pharmaceuticals, Inc. ORMP 61.02 3.00 4.91 -4.77 -464.15
Cassava Sciences, Inc. SAVA 58.14 41.00 3.06 -12.75 76.71
SCYNEXIS, Inc. SCYX 48.69 0.00 10.23 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.00 47.00 0.98 -10.67 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 46.90 9.00 8.75 -14.00 -36.08
Lipocine, Inc. LPCN 39.90 0.00 9.50 -2.66 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.88 0.00 -2.48 -2.74 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.49 0.00 1.54 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.40 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
Sonoma Pharmaceuticals, Inc. SNOA 6.35 19.00 1.01 -2.04 -25.58
VIVUS, Inc. VVUS 6.27 73.00 -0.14 -0.21 -39.28
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Here is What Hedge Funds Think About Neos Therapeutics Inc (NEOS)

1d ago, source: YAHOO!

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will ...

Neos Therapeutics Inc.

1mon ago, source: MarketWatch

Ms. Beth P. Hecht is a Secretary, General Counsel & Senior Vice President at Xeris Pharmaceuticals, Inc. and an Independent Director at Neos Therapeutics, Inc. She is on the Board of Directors at ...

Neos Therapeutics to Present at BMO 2020 Prescriptions for Success Healthcare Conference

24d ago, source: YAHOO!

DALLAS and FORT WORTH, Texas, June 16, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system ...

Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval

20d ago, source: Xconomy

Dallas—The FDA late Monday approved Neos Therapeutics’ controlled-release version of an old ADHD therapy, methylphenidate. Neos (NASDAQ: NEOS) says its formulation of methylphenidate ...

Neos Therapeutics Reports First Quarter 2020 Financial Results

27d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

Neos Therapeutics Price:

18d ago, source: YCharts

There is no data for the selected date range. An error occurred. Please try again by refreshing your browser or contact us with details of your problem. The price of ...

Neos Therapeutics Earnings Yield

28d ago, source: YCharts

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The earnings yield measures the earnings per share that you receive for the price ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.